Antagonist activity at human TRPV1 expressed in CHO cells assessed as inhibition of capsaicin-induced Ca2+ influx at 10 uM incubated for 30 mins by FLIPR method
Antagonist activity at human TRPV1 expressed in CHO cells assessed as inhibition of capsaicin-induced Ca2+ influx incubated for 30 mins by FLIPR method
Antagonist activity at human TRPV1 expressed in CHO cells assessed as low pH-induced Ca2+ influx at 10 uM incubated for 30 mins at pH 5 by FLIPR method
Analgesic activity against capsaicin-induced pain mouse model assessed as reduction in time spent on foot licking behaviour at 10 mg/kg, ip administered 30 mins prior to capsaicin stimulation and measured after 5 mins
Antinociceptive activity in mouse assessed as reduction in acetic acid induced writhing response at 10 mg/kg, ip administered 30 mins prior to acetic acid administration and measured every 15 mins by abdominal constriction test
Antinociceptive activity against thermal-induced nociception mouse model assessed as increase in tail withdrawal latency at 10 mg/kg, ip measured after 30 mins by tail flick test
Analgesic activity against ip dosed capsaicin-induced pain mouse model assessed as reduction in time spent on foot licking behaviour administered 30 mins prior to capsaicin stimulation and measured after 5 mins
Antinociceptive activity in mouse assessed as reduction in acetic acid induced writhing response at 3 to 30 mg/kg, ip administered 30 mins prior to acetic acid administration and measured every 15 mins by abdominal constriction test
Antinociceptive activity against thermal-induced nociception mouse model assessed as increase in latency time of nociceptive response at 10 to 30 mg/kg, ip measured after 30 mins by tail flick test